Phase 2
Phase 3

ALS

Sponsor:

Merit E. Cudkowicz, MD

Code:

NCT04297683

Conditions

Amyotrophic Lateral Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zilucoplan

Verdiperstat

CNM-Au8

Pridopidine

SLS-005 Trehalose

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Merit E. Cudkowicz, MD on 2026-07-21.